Documentation-first supply · ISO 9001 · FSSC 22000 · Kosher · Halal

Tirzepatide

A dual GIP/GLP-1 sequence intermediate supplied as a lyophilised powder, released against a written specification and shipped under end-user declaration. Not for human or veterinary use.

01 — Release specification

What the lot is released against.

ParameterSpecification
AppearanceWhite to off-white lyophilised powder
Assay≥ 98.0% (HPLC) · peptide content ≥ 85% · total impurities ≤ 2.0%
Water content≤ 8.0% (Karl Fischer)
Residual solventWater / acetonitrile gradient, ICH Q3C class 3 trace
IdentityC225H348N48O68, MW 4813.45
StorageStore at −20 °C, dry, protected from light. Shelf life 24 months.
HS code2937.19 (indicative — confirm with your broker)
02 — Documentation

Issued with every lot.

Quality system ↗

COA per lot

Lot number, release date, every tested parameter and the analyst who signed it.

HPLC chromatogram

Full trace with retention time, column, mobile phase and integration method.

MS identity

Observed mass against calculated mass for the lot, with the spectrum.

Amino-acid composition

Residue-by-residue breakdown from total hydrolysis.

Water content (Karl Fischer)

Coulometric titration result against the limit the lot is released to.

SDS

16-section GHS-format safety data sheet in English, version-controlled.

Lot impurity summary

Each impurity with retention time, limit and measured value.

End-user declaration

Signed statement of intended non-clinical use, required before dispatch.

03 — Packaging & logistics

Pack sizes, MOQ and lead time.

Pack sizes1 g, 10 g, 100 g amber vial; 1 kg bulk on request
Minimum order1 g
Lead time10–15 days from stock
HS code2937.19 (indicative — confirm with your broker)
DispatchSealed, desiccant-protected packaging; courier or air freight per destination
04 — How it is supplied

Use and compliance.

Laboratory research and analytical method development by qualified laboratories, and evaluation by licensed manufacturers of dual GIP/GLP-1 sequence chemistry. Sold under end-user declaration only. No dosing, clinical or therapeutic information is supplied.

Compliance

For research use only

Supplied only to qualified laboratories for non-clinical research. No dosing, clinical or therapeutic information is provided. Certifications and country availability are confirmed per product and per shipment in writing.

05 — Keep reading

Related notes.

06 — Quotation

Send a specification, get a quotation.

Tell us grade, volume and destination market. Enquiries are answered within one business day; samples are available for qualified buyers.

WhatsApp